Related Experiment Video
Updated: May 27, 2026
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Obesity and reproductive dysfunction in women
Lisa J Moran1, Jodie Dodd, Victoria Nisenblat
1The Robinson Institute, Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, University of Adelaide, South Australia. lisa.moran@adelaide.edu.au
Endocrinology and Metabolism Clinics of North America
|November 24, 2011
Summary
Losing weight before conception can improve fertility and pregnancy outcomes for women. Addressing overweight and obesity is crucial for maternal and infant health, reducing risks during pregnancy.
Area of Science:
- Reproductive Health
- Maternal-Fetal Medicine
- Public Health
Background:
- Overweight and obesity represent a growing global health concern.
- These conditions are linked to numerous adverse health outcomes, including reduced quality of life.
- Specific risks include metabolic disturbances, reproductive issues, and complications during pregnancy.
Purpose of the Study:
- To examine the impact of overweight and obesity on female fertility.
- To investigate the association between maternal weight status and pregnancy outcomes.
- To evaluate the potential benefits of pre-conception weight loss.
Main Methods:
- Review of existing literature on obesity, fertility, and pregnancy.
- Analysis of data correlating body mass index (BMI) with conception rates.
- Examination of studies on maternal and infant health outcomes in relation to pre-pregnancy weight.
Main Results:
- Overweight and obesity significantly impair fertility in women.
- Increased maternal weight is associated with higher risks of adverse pregnancy outcomes for both mother and infant.
- Pre-conception weight loss shows potential to improve fertility and pregnancy health.
Conclusions:
- Weight management prior to conception is a critical factor for optimizing reproductive health.
- Addressing overweight and obesity can mitigate risks associated with infertility and pregnancy complications.
- Interventions promoting pre-conception weight loss may enhance maternal and infant well-being.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...